Julie D Klapstein is Director of AMEDISYS INC. Currently has a direct ownership of 14,341 shares of AMED, which is worth approximately $1.21 Million. The most recent transaction as insider was on May 03, 2024, when has been sold 1,678 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.3K
0% 3M change
13.25% 12M change
Total Value Held $1.21 Million

Julie D Klapstein Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 03 2024
BUY
Grant, award, or other acquisition
-
1,678 Added 10.48%
14,341 Common Stock
May 03 2023
BUY
Grant, award, or other acquisition
-
1,941 Added 13.29%
12,663 Common Stock
Jun 09 2022
BUY
Grant, award, or other acquisition
-
1,304 Added 10.84%
10,722 Common Stock
Jun 08 2021
BUY
Grant, award, or other acquisition
-
574 Added 5.74%
9,418 Common Stock

Also insider at

OSH
Oak Street Health, Inc. Healthcare
MPLN
MultiPlan Corp Healthcare
NXGN
NEXTGEN HEALTHCARE, INC. Healthcare
JDK

Julie D Klapstein

Director
Chicago, IL

Track Institutional and Insider Activities on AMED

Follow AMEDISYS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMED shares.

Notify only if

Insider Trading

Get notified when an Amedisys Inc insider buys or sells AMED shares.

Notify only if

News

Receive news related to AMEDISYS INC

Track Activities on AMED